What is the typical starting dose of acetazolamide (carbonic anhydrase inhibitor) for a general adult population without specific comorbidities or age-related considerations?

Acetazolamide Dosing in Adults

For most general adult indications, start acetazolamide at 250 mg twice daily (500 mg total daily dose) and titrate upward based on clinical response and tolerability. 1, 2

Standard Dosing by Indication

Glaucoma

• Chronic open-angle glaucoma: 250 mg to 1 g per 24 hours in divided doses (doses >250 mg should be divided) 3
• Dosages exceeding 1 g per 24 hours typically do not produce increased therapeutic effect 3
• Acute/secondary glaucoma: 250 mg every 4 hours, though some cases respond to 250 mg twice daily 3
• For acute cases requiring rapid IOP reduction: initial 500 mg dose followed by 125-250 mg every 4 hours 3

Epilepsy

• Total daily dose: 8-30 mg/kg in divided doses 3
• Optimal range: 375-1000 mg daily, with most patients responding in this range 3
• When adding to existing anticonvulsants, start with 250 mg once daily and titrate upward 3
• Doses exceeding 1 g daily may not provide additional benefit 3

Congestive Heart Failure (Diuresis)

• Starting dose: 250-375 mg once daily in the morning 3
• Use alternate-day dosing or 2 days on/1 day off to allow kidney recovery 3
• Do not increase dose if edema persists; instead skip a day to allow renal recovery 3

Drug-Induced Edema

• 250-375 mg once daily for 1-2 days, alternating with a day of rest 3

Altitude Sickness Prevention

• Low-dose regimen: 125 mg twice daily (250 mg total daily) is as effective as higher doses and preferred 4, 5
• This dose provides similar AMS prevention (24% incidence) compared to 375 mg twice daily (21% incidence) with fewer side effects 4
• Begin 1-3 days prior to ascent and continue during initial days at altitude 6

Critical Dosing Considerations

Titration Strategy

• Start low at 250-500 mg twice daily to minimize side effect burden, particularly paresthesias which affect nearly 50% of patients 7, 2
• Gradual upward titration improves tolerability—only 44% of patients tolerate maximum 4 g daily doses in trials 7, 1
• Nearly half (48%) of patients discontinue at mean doses of 1.5 g daily due to adverse effects 1, 2

Renal Impairment

• Severe dose reduction required in renal failure: elimination half-life extends from 5-10 hours to 28.5 hours in ESRD 8
• In dialysis patients, reduce to 125 mg daily or less to prevent accumulation and toxicity 8
• Therapeutic serum range is 5-10 mcg/mL; levels of 17-27 mcg/mL (as seen with standard dosing in ESRD) cause lethargy and toxicity 8

Common Pitfalls

• Avoid continuous daily dosing for diuresis: intermittent dosing (alternate days or 2 on/1 off) is essential for kidney recovery and sustained efficacy 3
• Don't exceed 1 g daily for glaucoma or epilepsy without clear benefit, as higher doses rarely improve outcomes 3
• Monitor for dose-dependent side effects: paresthesias, dysgeusia (1 in 18 patients), fatigue (1 in 11 patients), and cognitive slowing increase with higher doses 2

Contraindications and Warnings

• Sulfonamide allergy is an absolute contraindication 7
• Severe liver disease, adrenal failure, and hyperchloremic acidosis preclude use 7
• Pregnancy (FDA Category C) due to teratogenic risk 7, 2
• Risk of metabolic acidosis, hypokalemia, and renal stones requires monitoring 2

Route of Administration

• Oral route is preferred for all indications 3
• Intravenous administration is reserved for acute glaucoma requiring rapid IOP reduction 3
• Intramuscular administration is not recommended 3